STACY BROMLEY: Open Payments
NPI 1740340884 · MILAN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,789 in 98 payments from 26 companies in 2025. Trend: 2023 $114 · 2024 $1,424 · 2025 $1,789
Food & beverage: $1,789
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $214 |
| Novo Nordisk Inc | 9 | $194 |
| ABBVIE INC. | 13 | $140 |
| Axsome Therapeutics, Inc. | 5 | $138 |
| AstraZeneca Pharmaceuticals LP | 5 | $136 |
| Dexcom, Inc. | 5 | $99 |
| Abbott Laboratories | 4 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Amgen Inc. | 4 | $74 |
| Phathom Pharmaceuticals, Inc. | 9 | $71 |
Products named: MOUNJARO, Symbravo, BREZTRI, Ozempic, Dexcom G6 Transmitter, Wegovy, UBRELVY, JARDIANCE.
Industry payments across TN — which companies pay providers there.
